1. Home
  2. FTEL vs MIST Comparison

FTEL vs MIST Comparison

Compare FTEL & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fitell Corporation

FTEL

Fitell Corporation

HOLD

Current Price

$0.73

Market Cap

9.1M

Sector

N/A

ML Signal

HOLD

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$2.08

Market Cap

176.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTEL
MIST
Founded
2007
2003
Country
Australia
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1M
176.3M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
FTEL
MIST
Price
$0.73
$2.08
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
11.3M
10.1M
Earning Date
11-17-2025
11-12-2025
Dividend Yield
27.40%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,200,138.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.42
N/A
52 Week Low
$0.61
$0.63
52 Week High
$187.68
$3.06

Technical Indicators

Market Signals
Indicator
FTEL
MIST
Relative Strength Index (RSI) 38.18 42.75
Support Level $0.62 $1.90
Resistance Level $0.75 $2.22
Average True Range (ATR) 0.08 0.33
MACD 0.07 -0.07
Stochastic Oscillator 34.27 33.20

Price Performance

Historical Comparison
FTEL
MIST

About FTEL Fitell Corporation

Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: